A Phase I, Single Centre, Single-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZD8329 After Administration of Multiple Ascending Doses in Abdominally Obese But Otherwise Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 May 2011
At a glance
- Drugs AZD 8329 (Primary)
- Indications Obesity
- Focus Adverse reactions
- 09 May 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 09 May 2011 Status changed from suspended to completed as reported by ClinicalTrials.gov.
- 14 Mar 2011 Actual initiation date changed from Oct 2010 to Sep 2010 as reported by ClinicalTrials.gov.